Clark Wealth Partners’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.91K Sell
69
-12
-15% -$1.18K ﹤0.01% 360
2026
Q2
$8.38K Buy
81
+17
+27% +$1.52K ﹤0.01% 248
2026
Q1
$4.6K Sell
64
-43
-40% -$3.31K ﹤0.01% 347
2025
Q4
$8.49K Hold
107
– – 0.01% 262
2025
Q3
$8.49K Buy
107
+43
+67% +$2.95K 0.01% 262
2025
Q2
$4.42K Hold
64
– – ﹤0.01% 300
2025
Q1
$4.34K Hold
64
– – ﹤0.01% 282
2024
Q4
$2.87K Buy
+64
New +$3.59K ﹤0.01% 310

Other funds holding CVS

Clark Wealth Partners's CVS Position: Q3 2026 in Review

Clark Wealth Partners reduced its CVS Health (CVS) stake by 15% in Q3 2026, selling an estimated $1.18K and leaving 69 shares worth $5.91K. The position accounts for ﹤0.01% of the portfolio, ranked #360.

Clark Wealth Partners first reported a position in CVS in Q4 2024 and has held it in 8 quarters since. The position peaked at $8.49K in Q4 2025. 1,724 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • Clark Wealth Partners held 69 shares of CVS Health worth $5.91K as of Q3 2026.
  • Clark Wealth Partners sold 12 CVS Health shares in Q3 2026, an estimated $1.18K.
  • CVS Health made up ﹤0.01% of Clark Wealth Partners's portfolio in Q3 2026, its #360 holding.
  • Clark Wealth Partners first reported a position in CVS Health in Q4 2024 and has held it in 8 quarters since.
  • Clark Wealth Partners's CVS Health position peaked at $8.49K in Q4 2025.
  • 1,724 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on Clark Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.